MH vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

MH

65.2
AI Score
VS
MH Wins

UTI

56.3
AI Score

Investment Advisor Scores

MH

65score
Recommendation
BUY

UTI

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MH UTI Winner
Revenue 1.18B 661.15M MH
Net Income 144.24M 15.54M MH
Net Margin 12.2% 2.4% MH
Operating Income 255.33M 19.27M MH
ROE 16.4% 4.5% MH
ROA 2.5% 1.7% MH
Total Assets 5.71B 897.86M MH
Cash 232.96M 130.06M MH
Debt/Equity 2.87 0.46 UTI
Current Ratio 0.86 1.30 UTI
Free Cash Flow 140.76M -63.50M MH

Relative Price Performance (Last 90 Days)

MH 1M: -16.6% · 3M: -15.6% UTI 1M: +10.8% · 3M: -10.5%

Current Technical Phase

MH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.9 · Price: $11.06

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.7 · Price: $22.51

Fundamentals Snapshot

Metric MH UTI
Market Cap — —
Forward P/E 6.2 31.3
Trailing P/E 29.9 38.0
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.8% 0.6%
Operating Margin 0.2% 0.0%
EPS 0.36 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MH is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.